Insider · CIK 0002001938
Moses Makunje
Files at NUVB (Nuvation Bio Inc.). First filing -, latest -.
Moses Makunje files SEC Form 4 as officer at NUVB (Nuvation Bio Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Moses Makunje has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | NUVB Nuvation Bio Inc. | AGrant or award Class A Common Stock | +50,761 | $0.00 | $0 | 68,137 | Mar 3, 2026 |
| Feb 27, 2026 | NUVB Nuvation Bio Inc. | AGrant or award Stock Option (Right to Buy)derivative | +224,439 | $0.00 | $0 | 224,439 | Mar 3, 2026 |
Questions about Moses Makunje
Answered from the filings on this page, as of the latest one.
Is Moses Makunje buying or selling?
Moses Makunje has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Moses Makunje's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Moses Makunje has 0.
Where does Moses Makunje file Form 4?
Moses Makunje has filed Form 4 at NUVB (Nuvation Bio Inc.) as SEE REMARKS. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.